These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22126710)
1. The management of blood safety in the presence of uncertain risk: a United kingdom perspective. Watkins NA; Dobra S; Bennett P; Cairns J; Turner ML Transfus Med Rev; 2012 Jul; 26(3):238-51. PubMed ID: 22126710 [TBL] [Abstract][Full Text] [Related]
2. UK approach to assessing assays and filters designed to reduce the risk of transfusion-transmitted vCJD. Thomas S; Turner ML; Williamson LM Transfus Clin Biol; 2013 Sep; 20(4):405-11. PubMed ID: 23928183 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre. Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905 [TBL] [Abstract][Full Text] [Related]
4. Moving on from voluntary non-remunerated donors: who is the best blood donor? Allain JP Br J Haematol; 2011 Sep; 154(6):763-9. PubMed ID: 21539535 [TBL] [Abstract][Full Text] [Related]
5. Who should donate blood? Policy decisions on donor deferral criteria should protect recipients and be fair to donors. Brailsford SR; Kelly D; Kohli H; Slowther A; Watkins NA; Transfus Med; 2015 Aug; 25(4):234-8. PubMed ID: 26190553 [TBL] [Abstract][Full Text] [Related]
6. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients. Klausen SS; Hervig T; Seghatchian J; Reikvam H Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310 [TBL] [Abstract][Full Text] [Related]
7. Emerging viral infections‑-a potential threat for blood supply in the 21st century. de Mendoza C; Altisent C; Aznar JA; Batlle J; Soriano V AIDS Rev; 2012; 14(4):279-89. PubMed ID: 23258302 [TBL] [Abstract][Full Text] [Related]
8. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
9. Lessons from the response to the threat of transfusion-transmitted vCJD in Ireland. Murphy WG Transfus Clin Biol; 2013 Sep; 20(4):416-21. PubMed ID: 24001606 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden. Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409 [TBL] [Abstract][Full Text] [Related]
11. The status of blood safety in ECO member states. Seighali F; Hosseini Divkolaye NS; Koohi E; Pourfathollah AA; Rahmani AM Blood Transfus; 2015 Oct; 13(4):583-7. PubMed ID: 26192779 [TBL] [Abstract][Full Text] [Related]
13. Multilayer-strategy to enhance optimal safety of the blood supply: The role of pathogen inactivation for optimizing recipient safety and helping health care cost containment: Moderator views. Seghatchian J Transfus Apher Sci; 2015 Apr; 52(2):233-6. PubMed ID: 25748230 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland. Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387 [TBL] [Abstract][Full Text] [Related]
15. Status of blood banking and the blood supply in Afghanistan. Ayyoubi MT; Konstenius T; McCullough JC; Eastlund T; Clay M; Bowman R; Rahmani AM; Riley W; McCullough J Transfusion; 2010 Mar; 50(3):566-74. PubMed ID: 19951318 [TBL] [Abstract][Full Text] [Related]
16. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Soldan K; Davison K; Dow B Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312 [TBL] [Abstract][Full Text] [Related]
17. Effect of a national disaster on blood supply and safety: the September 11 experience. Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH; JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136 [TBL] [Abstract][Full Text] [Related]
18. Human T-lymphotropic virus and transfusion safety: does one size fit all? Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300 [TBL] [Abstract][Full Text] [Related]
19. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858 [TBL] [Abstract][Full Text] [Related]
20. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule. Food and Drug Administration, HHS Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]